Tuberculosis

Company withdraws vaccine from the market in Britain

Published in Vaccine Weekly, September 11th, 2002

A company is voluntarily withdrawing its tuberculosis vaccine from the market in Britain as a precautionary measure, it said August 9, 2002.

PowderJect Pharmaceuticals, PLC, said it made the move regarding its BCG [bacillus Calmette-Guerin] vaccine, which is used in schools, after being notified of an interim suspension of the company's license for the vaccine in Ireland. That move followed testing that found a small number of batches did not meet the end-of-shelf-life specification, the company said in a statement.

"The regulators are satisfied that there are no related safety implications, although the batches were potentially less potent than...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry